C10 医药综合 标准查询与下载
共找到 274 条与 医药综合 相关的标准，共 19 页
1.1 This specification covers the size, color and pattern, and type used on labels applied to unlabeled syringes filled by the users or their agents to identify the drug content. This specification is not intended to cover labels applied by the drug manufacturer.
Standard Specification for User Applied Drug Labels in Anesthesiology
- ICS
- 11.040.20 (Transfusion, Infusion)
- CCS
- C10
- 发布
- 2006
- 实施
1.1 This terminology covers process analytical technology in the pharmaceutical industry. Terms are defined as they are used relative to the PAT framework in the pharmaceutical industry. Terms that are generally understood and in common usage or adequately defined in other readily available references are not included except where particular delineation to process analytical technology may be more clearly stated.1.2 This terminology is therefore intended to be selective of terms used generally in process analytical technology as it is applied in the pharmaceutical industry and published in a number of documents, such as those listed in the succeeding sections. The listing is also intended to define terms that appear prominently within other related ASTM standards and do not appear elsewhere.1.3 The definitions are substantially identical to those published by the U.S. Food and Drug Administration and other authoritative bodies, such as ISO, IEC, ITU, and national standards organizations.1.4 This terminology supplements current documents on terminology that concentrate on process analytical technology as it is applied in the pharmaceutical industry.1.5 An increasing number of product designations and designations for chemical, physical, mechanical, analytical, and statistical tests and standards are coming into common usage in the literature, regulatory environment, and commerce associated with process analytical technology in the pharmaceutical industry. Section 2 lists those documents referenced in this terminology.
Standard Terminology Relating to Process Analytical Technology in the Pharmaceutical Industry
- ICS
- 01.040.11 (Health care technology (Vocabularies));
- CCS
- C10
- 发布
- 2005
- 实施
1.1 This terminology covers process analytical technology in the pharmaceutical industry. Terms are defined as they are used relative to the PAT framework in the pharmaceutical industry. Terms that are generally understood and in common usage or adequately defined in other readily available references are not included except where particular delineation to process analytical technology may be more clearly stated.1.2 This terminology is therefore intended to be selective of terms used generally in process analytical technology as it is applied in the pharmaceutical industry and published in a number of documents, such as those listed in the succeeding sections. The listing is also intended to define terms that appear prominently within other related ASTM standards and do not appear elsewhere.1.3 The definitions are substantially identical to those published by the U.S. Food and Drug Administration and other authoritative bodies, such as ISO, IEC, ITU, and national standards organizations.1.4 This terminology supplements current documents on terminology that concentrate on process analytical technology as it is applied in the pharmaceutical industry.1.5 An increasing number of product designations and designations for chemical, physical, mechanical, analytical, and statistical tests and standards are coming into common usage in the literature, regulatory environment, and commerce associated with process analytical technology in the pharmaceutical industry. Section 2 lists those documents referenced in this terminology.
Standard Terminology Relating to Process Analytical Technology in the Pharmaceutical Industry
- ICS
- 01.040.11 (Health care technology (Vocabularies));
- CCS
- C10
- 发布
- 2005
- 实施
1.1 This terminology covers process analytical technology in the pharmaceutical industry. Terms are defined as they are used relative to the PAT framework in the pharmaceutical industry. Terms that are generally understood and in common usage or adequately defined in other readily available references are not included except where particular delineation to process analytical technology may be more clearly stated.1.2 This terminology is therefore intended to be selective of terms used generally in process analytical technology as it is applied in the pharmaceutical industry and published in a number of documents, such as those listed in the succeeding sections. The listing is also intended to define terms that appear prominently within other related ASTM standards and do not appear elsewhere.1.3 The definitions are substantially identical to those published by the U.S. Food and Drug Administration and other authoritative bodies, such as ISO, IEC, ITU, and national standards organizations.1.4 This terminology supplements current documents on terminology that concentrate on process analytical technology as it is applied in the pharmaceutical industry.1.5 An increasing number of product designations and designations for chemical, physical, mechanical, analytical, and statistical tests and standards are coming into common usage in the literature, regulatory environment, and commerce associated with process analytical technology in the pharmaceutical industry. Section 2 lists those documents referenced in this terminology.
Standard Terminology Relating to Process Analytical Technology in the Pharmaceutical Industry
- ICS
- 01.040.11 (Health care technology (Vocabularies));
- CCS
- C10
- 发布
- 2005
- 实施
The procedures in this test method should be used for in vivo evaluation the antimicrobial activity of drug products applied topically to the skin that are intended to help prevent infection in minor cuts, scrapes and burns. This test method is applicable for testing liquids, ointments, powders, films, or dressing containing or impregnated with an antimicrobial for their effect to reduce an enhanced skin microflora or their effects to suppress the growth of the skin flora, or both.1.1 The tests described in this test method are designed to evaluate antimicrobial agents in formulations intended for use as first aid antiseptic products for their ability to reduce or suppress the growth, or both, of the skin microflora. 1.2 A knowledge of microbiological techniques is required for these procedures. 1.3 Performance of this procedure requires the knowledge of regulations pertaining to the protection of human subjects. (See CFR Parts 50 and 56.) 1.4 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard. 1.5 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
Standard Test Method for Evaluation of First Aid Antiseptic Drug Products
- ICS
- CCS
- C10
- 发布
- 2005
- 实施
이 규격은 기하학적 제품의 시방 및 검증을 위한 표준 온도에 대하여 규정한다.
Geometrical Product Specifications(GPS)-Standard reference temperature for geometrical product specification and verification
- ICS
- 17.040.00
- CCS
- C10
- 发布
- 2004-12-30
- 实施
- 2004-12-30
Elastomeric parts for parenterals and for devices for pharmaceuticals use - Part 3: Determination of released-particle count
- ICS
- 11.040.20
- CCS
- C10
- 发布
- 2004-05-01
- 实施
Users should refer corrections, additions, and comments to the NGA Operational Help Desk: 1-800 455 0899;commercial 314-263-4864; DSN 693-4864; or write to: Director, National Geospatial-Intelligence Agency, ATTN:ES, Mail Stop L-88, 4600 Sangamore Road,
DIGITAL BATHYMETRIC DATA BASE - VARIABLE RESOLUTION (DBDB-V)
- ICS
- 01.100.01
- CCS
- C10
- 发布
- 2004-03-31
- 实施
The purpose of this notice is to inform users of the change in preparing activity for this standard to the National Geospatial-Intelligence Agency (NGA).
VECTOR MAP (VMAP) LEVEL 0
- ICS
- 01.100.01
- CCS
- C10
- 发布
- 2004-03-31
- 实施
The purpose of this notice is to inform users of the change in name of the preparing activity from the Defense and Mapping Agency (DMA) to the National Geospatial-Intelligence Agency (NGA).
DMA SINGLE COLOR OVERPRINT LIMITED REVISION UPDATES (SCO)
- ICS
- 01.100.01
- CCS
- C10
- 发布
- 2004-03-31
- 实施
The purpose of this notice is to inform users of the change in name of the preparing activity from the Defense Mapping Agency (DMA) to the National Geospatial-Intelligence Agency (NGA).
JOINT OPERATIONS GRAPHIC SERIES 1501A AND 1501 (JOG AIR/GROUND)
- ICS
- 01.100.01
- CCS
- C10
- 发布
- 2004-03-31
- 实施
The purpose of this notice is to inform users of the change in name of the preparing activity from the Defense Mapping Agency (DMA) to the National Geospatial-Intelligence Agency (NGA).
DIGITAL CITIES DATA BASE (DCDB)
- ICS
- 01.100.01
- CCS
- C10
- 发布
- 2004-03-31
- 实施
Users should refer corrections, additions, and comments to the NGA Operational Help Desk: 1-
DIGITAL TERRAIN ELEVATION DATA (DTED)
- ICS
- 01.100.01
- CCS
- C10
- 发布
- 2004-03-31
- 实施
The purpose of this notice is to inform users of the change in name of the preparing activity from the Defense Mapping Agency (DMA) to the National Geospatial-Intelligence Agency (NGA).
VECTOR MAP (VMAP) LEVEL 1
- ICS
- 01.100.01
- CCS
- C10
- 发布
- 2004-03-31
- 实施
The purpose of this notice is to inform users of the change in name of the preparing activity from the Defense Mapping Agency (DMA) to the National Geospatial-Intelligence Agency (NGA).
DIGITAL BATHYMETRIC DATA BASE 5-MINUTE (DBDB5)
- ICS
- 01.100.01
- CCS
- C10
- 发布
- 2004-03-31
- 实施
The purpose of this notice is to inform users of the change in name of the preparing activity from the National Imagery and Mapping Agency (NIMA) to the National Geospatial-Intelligence Agency (NGA), effective 24 October 2003.
URBAN VECTOR MAP (UVMAP) [Use In Lieu Of: DOD MIL-PRF-0089035]
- ICS
- 01.100.01
- CCS
- C10
- 发布
- 2004-03-31
- 实施
The purpose of this notice is to inform users of the change in name of the preparing activity from the Defense and Mapping Agency (DMA) to the National Geospatial-Intelligence Agency (NGA).
INTEGRATON OF RASTER PRODUCT FORMAT FILES INTO THE NATIONAL IMAGERY TRANSMISSION FORMAT
- ICS
- 01.100.01
- CCS
- C10
- 发布
- 2004-03-31
- 实施
The purpose of this notice is to inform users of the change in name of the preparing activity from the Defense Mapping Agency (DMA) to the National Geospatial-Intelligence Agency (NGA).
ARC DIGITIZED RASTER GRAPHICS
- ICS
- 01.100.01
- CCS
- C10
- 发布
- 2004-03-31
- 实施
Child-resistant non-reclosable packaging for pharmaceutical products - Requirements and testing; German version EN 14375:2003
- ICS
- 11.120.99;55.020;97.190
- CCS
- C10
- 发布
- 2004-02
- 实施
